Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trileptal monotherapy in pediatric partial seizures
NCT00050947Phase 3Completed
- Sponsor
- Novartis
- Start
- Jul 2002
- Primary completion
- Feb 2004
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of oxcarbazepine in Focal epilepsy (FE), sponsored by Novartis. Started Jul 2002; status: completed.
02
Drugs
oxcarbazepine
03
Conditions
Focal epilepsy (FE)
Beyond the preview
Go deeper on NCT00050947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00050947.